bioMérieux

As a practicing physician, I’ve experienced firsthand how challenging it can be to diagnose respiratory illnesses based on symptoms alone. Many infections can present in similar ways, making it difficult to know what's driving a patient's illness. Respiratory testing helps fill those gaps by providing information and clarity clinicians need to make informed treatment decisions. That's especially important during respiratory season when multiple pathogens are circulating widely in our communities.

Get the latest jobs and industry news

💬 “In an outbreak like this, bioMérieux’s role is not to step in as a supplier. We step in as a public health partner.” – Vanina Laurent-Ledru, Chief Public Health Officer for bioMérieux. In addition to coordinating with health ministries and bringing instruments and tests into the field, our teams have also been providing training to ensure that tests are used correctly. Our goal is to equip labs and healthcare professionals to strengthen the national capacity to respond to the Ebola outbreak—and future infectious disease outbreaks as well. 💡 Visit our website for further information about our public health mission and response to the current Ebola outbreak: http://spkl.io/60497G9Q7

📖 Our 2025 Annual Report is now available! Explore the achievements and milestones that helped make the world a healthier place.

Investir dans le diagnostic, c’est investir dans l’avenir de notre système de santé. Plus qu’une conviction, c’est une réalité que nous démontrons chaque jour : le diagnostic in vitro joue un rôle essentiel pour améliorer la pertinence et l’efficience des parcours de soins. Il contribue à optimiser les dépenses de santé et à faire face aux défis liés à l’accès aux soins (déserts médicaux, désengorgement des urgences), tout en renforçant la qualité de la prise en charge des patients. ✅ Les apports du diagnostic sont multiples : prise en charge plus rapide et mieux ciblée, hospitalisation évitée ou réduite, diminution des infections nosocomiales et des complications liées aux traitements inadaptés… Dans un récent article, la Revue Parlementaire met en lumière l’importance stratégique du diagnostic comme levier d’innovation et de performance pour notre système de santé. ⤵️

A new milestone for bioMérieux in the equine veterinary sector. 📢 We are announcing today the launch of two immunoassays dedicated to equine endocrinology: VIDAS® Equine INSULIN and VIDAS® Equine ACTH. Endocrine disorders such as Equine Metabolic Syndrome (EMS) and Equine Cushing’s disease (Pituitary Pars Intermedia Dysfunction – PPID) affect between 18% and 27% of senior horses. These conditions significantly increase the risk of complications, particularly chronic laminitis — making early and reliable testing essential for equine health. ➡️ By delivering fast, laboratory-quality results directly at horse care centers, these new assays enable veterinarians to make quicker, better-informed decisions. With more than 60 years of expertise in clinical diagnostics, we are now bringing its cutting-edge innovation to veterinary medicine. 📰 Read our full press release: http://spkl.io/6041AgwFF #PioneeringDiagnostics